drugset / Trial / NCT01508117
Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the addition of an investigational medication, axitinib, to radiation therapy will improve the outcome of treatment in patients, above the age of 70.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | 5 mg | — |